Colgate-Palmolive
CL | NYSE
$86.26
-$1.21 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$86.48
+$0.22 (+0.26%)
After-hours:
Sep 21, 2026, 7:43 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.05B | 20.8B | 20.38B | 20.1B | 20B | 19.95B | 20.1B | 20.11B | 19.99B | 19.75B | 19.46B | 19.14B | 18.68B | 18.34B | 17.97B | 17.74B | 17.7B | 17.48B | 17.42B | 17.34B | 17.08B | 16.72B |
Cost of Revenue | 8.33B | 8.31B | 8.13B | 8.01B | 7.89B | 7.83B | 7.94B | 7.98B | 8.06B | 8.1B | 8.14B | 8.19B | 8.07B | 7.97B | 7.74B | 7.53B | 7.4B | 7.17B | 7.04B | 6.87B | 6.7B | 6.53B |
Gross Profit | 12.72B | 12.49B | 12.25B | 12.09B | 12.11B | 12.11B | 12.16B | 12.12B | 11.93B | 11.65B | 11.32B | 10.95B | 10.61B | 10.37B | 10.23B | 10.22B | 10.3B | 10.31B | 10.38B | 10.47B | 10.38B | 10.19B |
Operating Income | 4.35B | 4.41B | 4.33B | 4.34B | 4.36B | 4.43B | 4.54B | 4.59B | 4.54B | 4.42B | 4.2B | 4B | 3.85B | 3.71B | 3.74B | 3.77B | 3.84B | 3.93B | 3.98B | 4.03B | 4.06B | 4.04B |
Interest Income | 72M | 76M | 75M | 73M | 52M | 31M | 16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.94B | 3B | 3.06B | 3.95B | 3.94B | 3.94B | 3.96B | 3.95B | 3.92B | 3.8B | 3.39B | 2.54B | 2.47B | 2.43B | 2.66B | 2.85B | 2.81B | 2.93B | 3.09B | 3.66B | 3.77B | 3.71B |
Net Income | 2.04B | 2.09B | 2.13B | 2.91B | 2.91B | 2.9B | 2.89B | 2.87B | 2.84B | 2.61B | 2.3B | 1.59B | 1.5B | 1.6B | 1.79B | 1.93B | 1.94B | 2.04B | 2.17B | 2.67B | 2.73B | 2.66B |
Selling & General & Admin | 8.26B | 8.12B | 7.95B | 7.77B | 7.78B | 7.75B | 7.79B | 7.7B | 7.52B | 7.31B | 7.13B | 6.96B | 6.77B | 6.66B | 6.49B | 6.45B | 6.46B | 6.38B | 6.41B | 6.44B | 6.32B | 6.15B |
Research & Development | n/a | n/a | n/a | 355M | 355M | 355M | 355M | 343M | 343M | 343M | 343M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -34M | -31M | -24M | -379M | -374M | -425M | -516M | -504M | -469M | -421M | -343M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.23B | 8.09B | 7.92B | 7.75B | 7.76B | 7.68B | 7.63B | 7.54B | 7.39B | 7.23B | 7.13B | 6.96B | 6.77B | 6.66B | 6.49B | 6.45B | 6.46B | 6.38B | 6.41B | 6.44B | 6.32B | 6.15B |
Interest Expense | 255M | 264M | 268M | 270M | 259M | 250M | 242M | 238M | 242M | 238M | 234M | 227M | 207M | 180M | 153M | 121M | 179M | 173M | 175M | 186M | 124M | 134M |
Selling & Marketing Expenses | 674M | 1.35B | 1.35B | 1.35B | 1.37B | 1.4B | 2.07B | 2.07B | 1.38B | 672M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.55B | 16.39B | 16.05B | 15.75B | 15.64B | 15.51B | 15.57B | 15.52B | 15.45B | 15.33B | 15.26B | 15.14B | 14.83B | 14.63B | 14.22B | 13.98B | 13.86B | 13.55B | 13.45B | 13.32B | 13.02B | 12.68B |
Income Tax Expense | 780M | 783M | 799M | 901M | 885M | 894M | 905M | 919M | 918M | 1.03B | 937M | 798M | 799M | 648M | 693M | 740M | 702M | 712M | 749M | 815M | 865M | 869M |
Shares Outstanding (Basic) | n/a | 802.3M | 804.7M | 807.8M | 807.61M | 817.7M | 817.7M | 817.7M | 819.7M | 822.8M | 823.4M | 825.6M | 829.4M | 831.4M | 832.6M | 835.7M | 836.8M | 840.6M | 842.1M | 843.6M | 845.6M | 848.6M |
Shares Outstanding (Diluted) | n/a | 805.1M | 804.7M | 810.2M | 816.48M | 822.5M | 822.5M | 822.5M | 823.7M | 825.9M | 825.1M | 827.3M | 831.3M | 833M | 834.4M | 838.5M | 839.4M | 843.7M | 845M | 846.4M | 849.4M | 851.4M |
EPS (Basic) | 2.54 | 2.59 | 2.63 | 3.59 | 3.58 | 3.55 | 3.53 | 3.49 | 3.45 | 3.17 | 2.79 | 1.93 | 1.81 | 1.92 | 2.14 | 2.31 | 2.32 | 2.43 | 2.56 | 3.14 | 3.20 | 3.11 |
EPS (Diluted) | 2.52 | 2.57 | 2.62 | 3.57 | 3.56 | 3.54 | 3.52 | 3.49 | 3.45 | 3.16 | 2.78 | 1.92 | 1.80 | 1.92 | 2.13 | 2.30 | 2.31 | 2.42 | 2.56 | 3.13 | 3.19 | 3.10 |
EBITDA | 3.69B | 3.89B | 3.95B | 4.81B | 4.78B | 4.8B | 4.8B | 4.8B | 4.76B | 4.63B | 4.19B | 3.32B | 3.22B | 3.14B | 3.36B | 3.53B | 3.55B | 3.66B | 3.82B | 4.4B | 4.44B | 4.39B |
EBIT | 2.18B | 3.25B | 3.32B | 4.2B | 4.19B | 4.19B | 4.2B | 4.19B | 4.16B | 4.04B | 3.63B | 2.76B | 2.68B | 2.61B | 2.81B | 2.97B | 2.99B | 3.1B | 3.26B | 3.84B | 3.9B | 3.84B |
Depreciation & Amortization | 487M | 638M | 630M | 605M | 597M | 603M | 605M | 607M | 601M | 589M | 567M | 552M | 542M | 535M | 545M | 552M | 558M | 557M | 556M | 553M | 547M | 543M |
Add to Watchlist
Select watchlists to add or remove CL